Trinidad & Tobago Wellness Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trinidad & Tobago Wellness Today.

Press releases published on September 22, 2026

Sep. 22, 2026

Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System

Indeterminate GlobeNewswire

Sep. 22, 2026

Reviva to Participate in the Lytham Partners Fall 2026 Investor Conference

Indeterminate GlobeNewswire

Sep. 22, 2026

Clene to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 22, 2026

Medera Expands Singapore Presence Through Partnership with National Heart Centre Singapore

Indeterminate GlobeNewswire

Sep. 22, 2026

Adagene Announces NMPA Clearance of Investigational New Drug Application for ADG138, a Novel HER2xCD3 Double-Masked Bispecific T-Cell Engager

Indeterminate GlobeNewswire

Sep. 22, 2026

Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire

Sep. 22, 2026

Recludix Pharma to Present at the Oppenheimer Private Life Sciences Company Showcase

Indeterminate GlobeNewswire

Sep. 22, 2026

PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology

Indeterminate GlobeNewswire

Sep. 22, 2026

SCYNEXIS Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to its Board of Directors

Indeterminate GlobeNewswire

Sep. 22, 2026

OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath

Indeterminate GlobeNewswire

Sep. 22, 2026

Sentient Media Mapped Every Factory Farm in Iowa and We’re Releasing the Data for Free

Indeterminate GlobeNewswire

Sep. 22, 2026

Envisagenics and Boehringer Ingelheim Enter Multi-Target Collaboration to Develop First-in-Class Precision Therapies Based on RNA Splicing-Derived Targets for Hard-to-Treat Cancers

Indeterminate GlobeNewswire

Sep. 22, 2026

Adventist Health Bakersfield Introduces Kern County’s First Next Generation Robotic-Assisted Bronchoscopy

Indeterminate GlobeNewswire

Sep. 22, 2026

Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy

Indeterminate GlobeNewswire

Sep. 22, 2026

Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies

Indeterminate GlobeNewswire

Sep. 22, 2026

Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens

Indeterminate GlobeNewswire

Sep. 22, 2026

Lymphatic Malformation Alliance (LMA) Meets with FDA Leadership to Elevate Awareness of Lymphatic Malformations and Advance the Urgent Need for Approved Treatments

Indeterminate GlobeNewswire

Sep. 22, 2026

Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365

Indeterminate GlobeNewswire

Sep. 22, 2026

Cerenome Secures In-Network Agreement with Blue Cross Blue Shield of Michigan, Expanding CNSide® Contracted Coverage to Approximately 158 Million Covered Lives

Indeterminate GlobeNewswire

Sep. 22, 2026

Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer

Indeterminate GlobeNewswire